Aurinia Pharmaceuticals AUPH
NASDAQ AUPH
$15.83 -0.12 (-0.75%)
At close: Oct 2, 2026 · 4:00 PM EDT

Aurinia Pharmaceuticals (AUPH) Return on Equity [ROE] (2020 - 2026)

Updated

Aurinia Pharmaceuticals' Return on Equity [ROE] was 53.12% in Q2 2026, up 35.43 percentage points from 17.69% a year earlier and up 1.21 percentage points from the prior quarter.

Analysis

Aurinia Pharmaceuticals (AUPH) Return on Equity [ROE] (2020 - 2026) Analysis & Trends

For FY2025, Return on Equity [ROE] at Aurinia Pharmaceuticals came in at 59.91%, up 58.39 percentage points from FY2024.

  • Return on Equity [ROE] has now increased for four consecutive years, with a five-year change of +88.98 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Equity [ROE] was 1.52% in FY2024 (+21.44 pp), -19.92% in FY2023 (+4.54 pp), -24.46% in FY2022 (+16.35 pp) and -40.81% in FY2021 (-11.74 pp).
  • Quarterly Return on Equity [ROE] has moved between -49.40% (Q3 2021) and 60.66% (Q4 2025) over five years.
  • Compared with a year earlier, Return on Equity [ROE] has increased for 17 straight quarters, with an average year-over-year change of +32.34 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Equity [ROE] over five years was Q4 2025 (a gain of 59.16 percentage points); the worst was Q4 2021 (a drop of 21.43 percentage points).
  • Per Business Quant data, AUPH's Return on Equity [ROE] in the three quarters before Q2 2026 was 51.91% (Q1 2026), 60.66% (Q4 2025) and 22.22% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 25.32%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.21%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 84.40%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 21.39%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 83.75%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -18.38%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.97%
10 Aurinia Pharmaceuticals 2.10 Bn 532.21 Mn 76.67 Mn 53.12%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 53.12%
Mar 31, 2026 51.91%
Dec 31, 2025 60.66%
Sep 30, 2025 22.22%
Jun 30, 2025 17.69%
Mar 31, 2025 10.94%
Dec 31, 2024 1.49%
Sep 30, 2024 -6.01%
Jun 30, 2024 -13.92%
Mar 31, 2024 -16.97%
Dec 31, 2023 -20.27%
Sep 30, 2023 -19.69%
Jun 30, 2023 -18.59%
Mar 31, 2023 -24.32%
Dec 31, 2022 -26.10%
Sep 30, 2022 -27.26%
Jun 30, 2022 -35.95%
Mar 31, 2022 -36.28%
Dec 31, 2021 -46.56%
Sep 30, 2021 -49.40%
API Access

Aurinia Pharmaceuticals Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=AUPH&period=max&api_key=YOUR_API_KEY